for discussion and consultation: our ideas for “health impact accounts” dr. armin h. fidler lead...
TRANSCRIPT
For Discussion and Consultation: Our Ideas for “Health Impact Accounts”
Dr. Armin H. FidlerLead Adviser, Health Policy and Strategy
The World Bank GroupBrussels, February 7, 2012
Outline
BackgroundRationaleChallenges to current approachThe need for Health Impact AccountsPrinciples for estimatesNext steps
Significant increase in DHA but challenges to sustain
• Recent scale-up of funding for health from domestic and donor sources
• Several reasons behind expansion of donor interest in health
• Following 2008 global fiscal crisis, donor countries are increasingly demanding clear evidence on the impact of their investment
Demand from donors and tax-payers for funding organizations to demonstrate results
Multilaterals, in the past, have had two options to respond to demand for evidence:
1. Ex-ante analyses of global costs and health benefits – Although ex-ante analyses of global costs and health benefits
have figured prominently in advocacy for global health programs7 these efforts are often based on the limited evidence-base available prior to major program scale-up.
2. Ex-post evaluations of investments. – These results are often delivered long after project is
completed and methods are not applicable to on-going review
A recent effort to communicate results: “Lives Saved”
3. Calculation of ‘lives saved’ to provide rapid estimates based on likely benefits from expenditures– Provide a timely, compelling, and perceived as meaningful
metrics for impact of investments in the health sector – While current Lives Saved approach should be applauded, it
does not take into account the entire health system when measuring outcomes
– Additionally, these results, while faster, face significant methodological and data challenges
• Due to current challenges, the World Bank has decided to revise (“upgrade”) its Lives saved methodology.
5
World Bank – IHME Collaboration on next Generation of Lives Saved
The World Bank has partnered with IHME to:• Preserve the benefits of initial Lives Saved approach with
timely, meaningful and compelling information with comprehensible estimates on the likely impact of health investments
• Create a framework for the next generation of investment impact accountability methodology
• Improve metrics that take into account all key components of the health system that contribute to success
6
Rationale
• Demand for metrics that convey the impact of DAH in a compelling, digestible and timely manner
• While current Lives Saved approach should be applauded, it does not take into account the entire health system when measuring outcomes
7
Lives Saved Approach: Key Challenges
• Current Lives Saved approach diminishes the importance of the role of Health System Investments–Most approaches attribute lives saved to
consumables or commodities– They neglect to take into account that the
effectiveness of such consumables and commodities depends upon their reaching patients and users
–Many components of the delivery-value-chain may be involved in this
8
Child Treated
Efficient Warehousing and wholesale
distribution
Currently, Impact linked mostly with commodity
Purchased Malaria Drug
Malaria treatment
Child Treated
Global R & D; country level quality control and licensing
Robust and Efficient Procurement
Efficient Warehousing and wholesale
distribution
Clinic, and trained health worker
Information and HH demand side mechanisms
But, effectiveness of treatment requires a well functioning malaria treatment value chain
Purchased Malaria Drug
Motivated and efficient Health
Worker, diagnosis and treatment
Malaria treatment
Key priority disease value chains share same critical components. Need for System approach to strengthen them
Interventions
Child Treated
Malaria Prevention through Bed-Net
Global R & D; country level quality control and licensing
Robust and Efficient Procurement
Efficient Warehousing and wholesale
distribution
Clinic, and trained health worker
Information and HH demand side mechanisms
Purchased Malaria Drug
Motivated and efficient Health
Worker, diagnosis and treatment
Mother Treated
Vertical HIV Transmission Prevention
Global R & D; country level quality control and licensing
Robust and Efficient Procurement
Efficient Warehousing and wholesale
distribution
Clinic, Laboratory and trained health worker
Information and HH demand side mechanisms
Purchased ARV
Motivated and efficient Health
Worker, diagnosis and treatment
Mother Consuming MN
Micro Nutrients Supplement During Pregnancy (Vit A)
Global R & D; country level quality control and licensing
Robust and Efficient Procurement
Efficient Warehousing and wholesale
distribution
Clinic, and trained health worker
Information and HH demand side mechanisms
Purchased Micro Nutrient
Motivated and efficient Health Worker, prescription and
provision
Regulatory Capacity (Stewardship)
Procurement Capacity
Consumable or commodity
Syst. Component
Logistics and Distribution
Communications; CCTs, Health
InsuranceWorker training,
hiring and retention;
Infrastructure
Provider Payment Mechanisms
Lives Saved Approach: Key Challenges
• Health Impact from Investments in Other Sectors are underestimated– For example, the impact of programs on
environmental pollution, transportation, and indoor air pollution are not yet assessed
– Currently included: education for young girls, road safety, water and sanitation
12Source: This is where your source copy goes.
Methodological Limitations
• Potential for double-counting– Current Live Saved methodologies have the potential for the
same life saved to be counted multiple times by different donor organizations
• Heterogeneity in the timing of benefits– Deaths prevented through one intervention can be nearly
instantaneous while for others it may be in years to come• Efficacy versus effectiveness
– Most information currently used comes from randomized clinical trials, but an extensive literature demonstrates that due to enhanced provider effort and exclusion criteria used in RCTs, the likely benefits in most scaled-up programs will be smaller
13
Moving Forward
•To sustain investments in global health– critical to quantify the likely health benefits of the current investment portfolios –communicate that impact in a timely and compelling manner.
• One way: “Health Impact Accounts”HIAs are a systematic assessment of the health impact of an investment portfolio compared to the counterfactual
14
1. Assess all investments in terms of critical value chains
•Improved health from investment comes through the delivery of interventions to improve health •First step to understanding investment impact is identifying the critical value chains involved in the implementation
15
2. Assess national changes in inputs and effective coverage for a value-chain
•HIA must take into account all actors influencing a value chain in a country•This requires the most information possible on NHAs, but in their absence, the projection of a secular trend in coverage that would have occurred without donor investments would suffice
16
Bednets Example
Hypothetical case of the trend in investment and coverage for a value-chain 17
GOV
ITN
Cov
erag
e
YEARstart year
secular
DAH
3. Allocate national changes in effective coverage to components and by investors in value-chain
•If one organization is investing in cold chains and health information and the other in financing vaccines, the overall changes in immunization coverage should be allocated accordingly
18
3. Allocate national changes in effective coverage to components and by investors in value-chain
• If there is clear evidence about the pay-off from different types of investments this should be taken into account
• If there is clear evidence that one donor is more efficient that others in investing DAH on value chain components, this should be taken into account
• Otherwise, all donors should be considered equally efficient
19
4. Estimate health impact from changes in coverage with evidence including national trends in health outcomes
•The strongest possible effort should be made to map the path for intervention to health gain•Take into account both demand and supply side factors to identify gap between efficacy and effectiveness
20
5. Health impact should be disaggregated into time periods and different metrics
•Different users of the HIA may want to understand when benefits should occur and what the magnitude of the gain is for the affected population
21
Deaths averted YLLs DALYs
Have accrued
Should accrue